TRIB

Q: What is the price of Trinity Biotech (TRIB) today?

The current price of Trinity Biotech (TRIB) is $ 0.64, representing a -9.45% gain over the past year. The stock began the year trading around $ 0.79 and is currently priced at $ 0.64. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Trinity Biotech (TRIB) pay dividends?

Trinity Biotech (TRIB) did not pay dividends over the past year.

Trinity Biotech PLC

Price

$ 0.64

return (12m)

-9.45%

p/e

-0.39

p/bv

-0.23

DIVIDEND YIELD

0.00%

TRIB price

TRIB

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment TRIB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.67%

3 months

-29.91%

1 year

-9.45%

2 years

-64.97%

5 years

-96.39%

10 years

-98.89%

Fundamentals TRIB

review the fundamentals of Trinity Biotech shares

P/E

-0.39

Sector: -2.28 Industry: -5.52

P/S (PSR)

0.26

Sector: 1.95 Industry: 2.87

P/BV

-0.23

Sector: 2.14 Industry: 2.11

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-29.33%

Sector: -26.12% Industry: -48.74%

ROE

58.98%

Sector: -29.89% Industry: -41.50%

ROIC

0.00%

Sector: -417.02% Industry: -485.80%

NET MARGIN

-64.75%

Sector: -28.23% Industry: -32.27%

GROSS MARGIN

33.64%

Sector: 44.62% Industry: 45.26%

OPERATING MARGIN

-30.40%

Sector: -23.34% Industry: -27.83%

EV/EBITDA

-0.67

Sector: -0.65 Industry: -2.51

EV/EBIT

-0.63

Sector: -1.83 Industry: -4.32

PRICE-TO-ASSETS

0.12

Sector: 1.15 Industry: 1.26

BVPS

-2.75

Sector: 3.79 Industry: 2.16

EPS

-1.62

Sector: -0.90 Industry: -1.33

EQUITY-TO-ASSETS RATIO

-0.50

Sector: 0.43 Industry: 0.49

LIABILITIES / ASSETS

1.50

Sector: 0.46 Industry: 0.42

CAGR REVENUE 5 YEARS

-0.11%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

70.18%

Sector: - Industry: -

Fundamentals TRIB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	38.33	33.17	86.53%	0.70%	$ 791.14 B	31.66%
ISRG	57.46	9.73	16.93%	0.00%	$ 171.19 B	28.15%
TMO	25.52	3.36	13.15%	0.37%	$ 174.73 B	15.15%
NVS	19.91	5.98	30.04%	2.13%	$ 278.48 B	24.67%
SNY	12.52	1.36	10.86%	4.73%	$ 114.19 B	18.68%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	23.17	2.17	9.38%	3.41%	$ 106.90 B	13.00%
GSK	14.35	5.12	35.71%	3.22%	$ 109.42 B	17.48%
CVS	55.99	1.31	2.35%	3.41%	$ 98.98 B	0.44%
BSX	25.86	0.00	0.00%	0.00%	$ 92.17 B	17.29%
TMDX	19.82	7.97	40.22%	0.00%	$ 3.77 B	31.43%
HCA	14.26	-32.53	-228.14%	0.68%	$ 96.87 B	8.89%
IDXX	42.73	28.20	65.99%	0.00%	$ 45.27 B	24.62%
RMD	21.60	5.08	23.51%	1.06%	$ 32.10 B	27.53%
DHR	34.02	2.37	6.97%	0.77%	$ 125.49 B	14.89%
INMD	9.67	1.33	13.73%	0.00%	$ 907.20 M	25.32%
PHG	25.18	2.03	8.06%	3.23%	$ 26.12 B	5.07%
FMS	11.54	0.78	6.75%	3.46%	$ 13.02 B	5.02%
SYK	38.64	5.59	14.48%	1.04%	$ 125.44 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

TRIB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/09/2015	07/01/2015	1,10000000
Dividends	06/10/2014	07/01/2014	1,10000000
Dividends	06/10/2013	07/01/2013	1,00000000
Dividends	06/08/2012	06/22/2012	0,75000000
Dividends	06/09/2011	06/23/2011	2,00000000

ABOUT Trinity Biotech

Trinity Biotech PLC

Average Investor10 user rating

4.0 (0 people)

United States

34 years

Founded: 1992

1992

Time since IPO - 34 years

543

Employees

Trinity Biotech PLC (United States) is listed on the Nasdaq and has a market capitalization of $11.54 Millions, with shareholders equity totaling $-49.54 Millions.

The company employs approximately 543 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Trinity Biotech PLC reported $45.13 Millions in revenue, generating net income of $-29.22 Millions.

Key financial metrics include a P/E ratio of -0.39, a price-to-book (P/B) ratio of -0.23, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TRIB.

Market cap

$ 11.54 Millions

Net worth

$ -49.54 Millions

$ -49,540,000.00

Assets

$ 99.63 Millions

$ 99,630,000.00

Total Shares Outstanding

18.00 Millions

18,000,000

Average Daily Trading Volume

$ 180.30 Thousand

$ 180,302.00

Sector

Health

Industry

Medical Supplies and Equipment

TRIB

TRIB revenue and profits

Financial Results TRIB

DRAG THE FRAME TO SEE MORE DATA

TRIB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.94 24,96% (12M)

P/E

55.99

3.41%

ROE

2.35%

P/BV

1.31

CI - Cigna

$ 275.64 --15,59% (12M)

P/E

10.67

2.21%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 41.82 --27,51% (12M)

P/E

-3.08

0.00%

ROE

-33.28%

P/BV

1.03

HUM - Humana

$ 215.23 --16,97% (12M)

P/E

21.74

1.64%

ROE

6.70%

P/BV

1.46

LLY - Eli Lilly

$ 883.96 1,49% (12M)

P/E

38.33

0.70%

ROE

86.53%

P/BV

33.17

HCA - HCA Healthcare

$ 432.46 32,78% (12M)

P/E

14.26

0.68%

ROE

-228.14%

P/BV

-32.53

NVS - Novartis

$ 145.42 32,22% (12M)

P/E

19.91

2.13%

ROE

30.04%

P/BV

5.98